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Earlier it has been shown that human proliferating/undifferentiated basal keratinocytes hold the full capacity for
autocrine catecholamine synthesis/degradation and express b2-adrenoceptors (b2-AR). In this report, we show that
human melanocytes also express all of the mRNA and enzymes for autocrine synthesis of norepinephrine but fail to
produce epinephrine. So far, it was established that human melanocytes express a1-AR which are induced by
norepinephrine yielding the inosine triphosphate diacylglycerol signal. The presence of catecholamine synthesis
and the b2-AR signal escaped deﬁnition at that time. Using RT-PCR, immunoﬂuorescence and radioligand binding
with the b2-AR antagonist ()[3H]CGP 12177, we show here that human melanocytes express functional b2-AR
(4230 receptors per cell) with a Bmax at 129.3 and a KD of 3.19 nM but lack b1-AR expression. b2-AR stimulation with
epinephrine 106 M and salbutamol 106–105 M yielded a strong cyclic adenosine monophospate (cAMP)
response in association with upregulated melanin production. Taken together these results indicate that the
biosynthesis and release of epinephrine (106 M) by surrounding keratinocytes can provide the cAMP response
leading to melanogenesis in melanocytes via the b2-AR signal. Moreover, the discovery of this catecholaminergic
cAMP response in melanocytes adds a new source for this important second messenger in melanogenesis.
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Catecholamines are a group of signalling molecules, which
serve two primary biological functions, acting as neuro-
transmitters and as endocrine hormones (Martini, 1999).
Earlier, it has been shown that human proliferating/undiffer-
entiated basal keratinocytes hold the full capacity for
autocrine catecholamine biosynthesis and degradation via
monoamine oxidase A (EC 1.4.3.4, MAO-A) and catechol-
O-methyltransferase (EC 2.1.1.6, COMT) (Schallreuter et al,
1992; Le Poole et al, 1994; Schallreuter et al, 1996a).
The rate-limiting step for catecholamine biosynthesis is
the conversion of L-tyrosine to L-dopa by tyrosine hydro-
xylase (EC 1.14.16.2, TH) (Nagatsu et al, 1964). TH-activity
depends on the availability of its essential cofactor/electron
donor 6R-L-erythro-5, 6, 7, 8-tetrahydrobiopterin (6BH4) to
form L-dopa. In this context, it has been shown that de novo
synthesis/recycling/regulation of 6BH4 occurs in both hu-
man epidermal keratinocytes and melanocytes (Schallreuter
et al, 1994a, b). L-dopa is converted to dopamine by
dopadecarboxylase (EC 4.1.1.28, DDC) in the presence of
pyridoxal phosphate. Subsequently, dopamine is oxidized
to norepinephrine by dopamine-b-hydroxylase (EC
1.14.17.1, DbH). The last enzyme phenylethanolamine-N-
methyltransferase (EC 2.1.1.28, PNMT) specifically cata-
lyses the synthesis of epinephrine from norepinephrine in
the presence of S-adenosyl-L-methionine (SAM) (for review
see Schallreuter et al, 1992) (Fig 1).
Nowadays, it is well established that catecholamine
signalling involves the activation of b2 adrenoceptors (b2-
AR) on the cell plasma membrane (Schramm and Selinger,
1984; Carafoli and Penniston, 1985; Gilman, 1987). The b2-
AR is a 64 kDa protein which belongs to the G-protein-
coupled receptor (GPCR) family (Robison et al, 1967). All
GPCR share a common architecture with seven transmem-
brane helices, where an intracellular domain is involved in
recognition and activation of G-proteins (Wess, 1997). The
G-proteins, which are heterotrimers made up of distinct a,
b and g subunits, transduce ligand binding to the GPCR
into an intracellular response. b-adrenergic receptors
activate adenylylcyclase (AC), leading to an increase in
intracellular cyclic adenosine monophospate (cAMP) con-
centrations followed by activation of protein kinase A (PKA)
and an increase in intracellular calcium (Koizumi et al, 1991;
Steinkraus et al, 1992; Yasui et al, 1992). Earlier, it has been
recognized that proliferation and differentiation of human
keratinocytes depend on calcium concentrations (Boyce
and Ham, 1983; Grando, 1997). An epidermal calcium
gradient with low calcium concentration in the basal layer
and increasing calcium concentrations in the upper layers
has been documented (Menon et al, 1985). Moreover, it has
also been shown that b2-AR density in the human epidermis
depends on the calcium concentration (Gazith and Reichert,
1982; Schallreuter et al, 1993), where undifferentiated
keratinocytes express approximately 7500 AR per cell and
Abbreviations: b2-AR, b2-adrenoceptor; DDC, dopadecarboxylase;
DbH, dopamine-b-hydroxylase; oligo DT, oligo deoxythymidine
triphosphate; PNMT, phenylethanolamine-N-methyltransferase;
POMC, pro-opiomelanocortins; TH, tyrosine hydroxylase
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differentiated keratinocytes express only 2500 receptors
underlining an important function for the b2-AR in the
differentiation process in human skin (Schallreuter et al,
1995).
But catecholamine synthesis in melanocytes escaped
recognition under the experimental conditions used at that
time (Schallreuter et al, 1992). It was later reported that
melanocytes express a1-AR yielding stimulation of the
inosine triphosphate/diacylglycerol signal cascade (Schall-
reuter et al, 1996b). At that time, it was assumed that these
receptors relied on norepinephrine synthesis by surrounding
keratinocytes and not by autocrine stimulation (Schallreuter
et al, 1996b). Only very recently the expression and
enzymatic function of tyrosine hydroxylase isoform I (TH-
1) was demonstrated in the cytosol of keratinocytes and
melanocytes and in melanosomes (Marles et al, 2003). The
presence of TH-1, side by side with tyrosinase on the
melanosomal membrane in association with L-dopa forma-
tion underlined the importance of L-dopa for activation of
tyrosinase in the control of pigmentation (Marles et al, 2003).
Moreover, the presence of TH-1 in the cytosol of melano-
cytes leads us to readdress the question whether these
cells express the other enzymes for complete biosynthesis
of catecholamines (i.e., DDC, DbH, and PNMT) together
with a functional b-AR signal. The results of this study
identified the presence of an autocrine norepinephrine
biosynthesis in melanocytes using RT-PCR and in vitro
and in situ immunofluorescence. RT-PCR showed the
presence of b2-AR mRNA but failed to detect b1-AR mRNA.
Saturation binding studies yielded 4230 b2-AR/cell with low
affinity (KD¼3.19 nM). Consequently, we tested the function
of the b2-AR in these cells under in vitro conditions by
following cAMP production and melanogenesis upon
stimulation with epinephrine or salbutamol. Our results
demonstrate a functional b2-AR signal on human melano-
cytes unmasking an additional cAMP source in these cells
in association with increased melanogenesis. Since it has
been established that the a-melanocyte stimulating hor-
mone (a-MSH)/cAMP cascade stimulates melanogenesis,
our findings indicate that the b2-AR/cAMP response also
contributes significantly to pigmentation (Abe et al, 1969a,
b; Pavel and Schwippelova, 1978; Miyazaki et al, 1984;
Thody et al, 1984; Abdel Malek et al, 1986a, b; Rees and
Flanagan, 1999).
Results
mRNA expression for enzymes in catecholamine synth-
esis in human epidermal melanocytes hTH-1-specific
RT-PCR assays clearly showed the expression of hTH-1
mRNA in undifferentiated keratinocytes (n¼ 2) and epider-
mal melanocytes (n¼2) (Fig 2a). Subsequent Pst 1
restriction analysis of the amplified product validated the
Figure 1
The catecholamine biosynthesis cascade. Tyrosine hydroxylase (TH)
requires 6R-L-erythro-5, 6, 7, 8-tetrahydrobiopterin (6BH4) as the
essential cofactor for the synthesis of L-tyrosine and L-dopa, which is
converted by dopadecarboxylase (DDC) in the presence of pyridoxal
phosphate to dopamine. This metabolite is used by dopamine-b-
hydroxylase (DbH) in the presence of ascorbate to form norepinephrine.
Phenylethanolamine-N-methyltransferase (PNMT) specifically cata-
lyses the reaction to epinephrine in the presence of S-adenosyl-L-
methionine (SAM).
Figure 2
(a) hTH-1 mRNA expression in human epidermal melanocytes and keratinocytes. Lane 1, negative control (no cDNA); lanes 2–3, two different
undifferentiated keratinocyte cell lines; lanes 4–5, two different melanocyte cell lines; lane 6, molecular weight marker–100 base pair (bp) DNA ladder.
The weaker expression in melanocytes could be attributed to the interference of melanin (Eckhart et al, 2000). (b) DDC mRNA expression in human
epidermal melanocytes and keratinocytes. Lane 1, negative control (no cDNA); lanes 2–3, epidermal undifferentiated keratinocytes; lanes 4–5,
epidermal melanocytes; lane 6, molecular weight marker–100 bp DNA ladder. (c) PNMT mRNA expression in human epidermal melanocyte and
keratinocyte cell cultures. Lane 1, negative control (no cDNA); lanes 2–3, two different undifferentiated keratinocyte cell lines, lanes 4–5, two different
melanocyte cell lines; lane 6, molecular weight marker–100 bp DNA ladder. To confirm the nature of the product obtained from the PNMT-PCR
reaction, the amplicon from lane 5 was sequenced and overlaid on the sequence of the PNMT gene (data not shown).
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assay (data not shown); however, mRNA expression for any
other TH isoforms could not be detected in either human
melanocytes or keratinocytes in vitro. Based on this result
it was concluded that human epidermal melanocytes and
keratinocytes do not express other isoforms of TH, except
hTH-1.
Figure 2b shows the expression of DDC mRNA in two
different undifferentiated keratinocyte and two different
melanocyte cell lines. Figure 2c shows the presence of
mRNA for PNMT in two different undifferentiated keratino-
cyte and two different melanocyte cell lines.
In summary, these results demonstrated the presence
of transcription for complete catecholamine synthesis in
melanocytes under in vitro conditions.
Protein expression of TH, DDC, DbH but not PNMT is
present in vitro in human epidermal melanocytes To
further substantiate the translation of the identified mRNA of
catecholamine biosynthesis in human melanocytes, cell
cultures were used for immunohistochemical detection. The
results presented in Fig 3a show the presence of TH as
‘‘cytoplasmic granules’’ with peri-nuclear and dendritic tip
accumulations. DDC staining identifies the presence of
cellular subpopulations where immature cells stain profu-
sely whereas the mature, multi-dendritic cells fail to stain
(Fig 3b). The results for DbH are similar; however, only a
small number of cells, approximately less than 10%, fail to
stain (Fig 3c). In each case, the pattern of staining appears
granular and is found in the majority of cells to be restricted
to the cell periphery and to the dendrites. The peri-nuclear
staining pattern, as demonstrated with TH, was not ob-
served for either DDC or DbH.
Figure 3d shows the absence of PNMT protein expres-
sion in melanocytes under the experimental conditions used
in this study. In order to ensure the specificity of the
antibody, we used undifferentiated keratinocytes of the
same culture age (p4), as positive controls (Fig 3d, iii ). This
result shows that despite the presence of mRNA, translation
of this last enzyme in the catecholamine synthesis is absent
in melanocytes under the experimental conditions used.
mRNA expression of b2-AR on human epidermal mela-
nocytes and sequence analysis of the PCR products
Figure 4 shows the expression of b2-AR mRNA on human
epidermal melanocytes. To our knowledge these results
demonstrate for the first time the transcription of the b2-AR
Figure 3
Immunohistochemical localization of
catecholaminergic enzymes in epider-
mal melanocytes. (a) Tyrosine hydroxy-
lase (TH) expression: (i) Undifferentiated
melanocytes (p3) with the typical bi-polar
morphology demonstrating TH in the peri-
nuclear region and in the tips of the
dendrites (scale bar¼10 mm). (ii) TH in
‘‘cytoplasmic granules’’ (p3) at higher
magnification (scale bar¼ 10 mm). (b)
Dopadecarboxylase (DDC) expression:
Distribution of DDC in melanocytes from
a maturing culture (p4) (i). Note the cellular
subpopulations with different levels of
staining (scale bar¼10 mm). (ii) At higher
magnification, the strongly positive cells
show a granular pattern (scale bar¼10
mm). Inset: Enlargement of the cell (scale
bar¼3 mm). (c) dopamine-b-hydroxylase
(DbH) expression: (i) Lower magnification
yields again a subpopulation of cells. The
positive cells demonstrate a granular
staining along the length of the dendrites,
whereas the peri-nuclear region shows
less expression (scale bar¼10 mm). (ii)
One example of a positive melanocyte at
higher power (scale bar¼3 mm). Insets:
The granular pattern of DbH at higher
magnification. Note the stronger expres-
sion towards the periphery of the cell and
in the dendrites (scale bar¼3 mm). (d)
Phenylethanolamine-N-methyltransferase
(PNMT) expression: (i) Melanocytes at low
magnification do not show PNMT expres-
sion (scale bar¼ 10 mm). (ii) PNMT is also
absent at higher magnification (scale
bar¼8 mm). (iii) Undifferentiated keratino-
cytes, used as positive controls, demon-
strate the expression of PNMT protein
(scale bar¼10 mm).
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in human epidermal melanocytes. To ensure the nature of
the product obtained from the RT-PCR assays, sequence
analysis was performed. The results confirmed that the
amplicons were indeed the targeted gene regions and not
spurious products of non-specific annealing (data not
shown); however, we were unable to detect b1-AR mRNA
in melanocytes under the experimental conditions used
(data not shown).
b2-AR protein is expressed in normal human melanocy-
tes In order to further substantiate successful translation of
mRNA expression for b2-AR on melanocytes, we performed
immunofluorescence on full-skin sections and on cell
cultures of melanocytes. b2-AR protein expression was
pronounced in undifferentiated/basal keratinocytes (Fig 5a).
This result is in agreement with higher levels of catechola-
mine biosynthesis and b2-AR expression in the proliferating
cells of the basal layer as described earlier (Schallreuter
et al, 1992). In addition, we identified melanocyte-specific
b2-AR expression by double immunostaining, using the
melanocyte-specific gp 100 protein (NKI/Beteb). b2-AR
expression on melanocytes in situ was visualized upon
overlaying of both fluorophores (Fig 5a, inset i). Further-
more, the presence of b2-AR protein expression was also
demonstrated in melanocytes under in vitro conditions
(Fig 5b).
Melanocytes express functioning low-afﬁnity b2-AR’s
with 4230 receptors/cell producing cAMP associated
with increased melanogenesis In order to determine the
density of receptors in melanocytes, specific saturation
binding assays were performed. The specific binding of
()[3H]CGP 12177 to human melanocytes is saturated as
a function of radioligand concentration. Figure 6 presents
the specific binding on human melanocytes. The number of
receptors present on each cell were calculated as outlined
in methods. Based on this calculation, each cell expressed
4230 receptors with a Bmax at 129.3 and a KD of 3.19 nM.
This result is in agreement with low-affinity b2-AR on
melanocytes; however, the receptor number on these cells
differs significantly from the receptor density and affinity on
undifferentiated keratinocytes, i.e., 7500 b2-AR/keratinocyte
and a KD of 0.095 nM (Steinkraus et al, 1991; Schallreuter
et al, 1993). To test the specificity and functionality of this
receptor, we investigated the b2-AR by following cAMP
production after epinephrine or salbutamol stimulation in
different concentrations. The results demonstrated a con-
centration-dependent cAMP production upon stimulation
with both epinephrine and salbutamol, confirming the low-
affinity response as indicated by the KD (Fig 6). The most
effective response was observed after 106 and 105 M
epinephrine or salbutamol stimulation (Figs 6 and 7). The
concentration of epinephrine is in the physiological range in
keratinocytes (Schallreuter et al, 1992). In order to test
the specific b2-AR/cAMP response on melanogenesis, cells
were incubated for 48 h with salbutamol. Figure 7b
demonstrates a concentration-dependent increase in mel-
anin content after exposure to this b2-AR specific agonist.
Discussion
To our knowledge, the results presented herein are original
and demonstrate the presence of norepinephrine biosynth-
esis in human melanocytes in association with a functioning
Figure 4
b2-adrenoceptor (b2-AR) mRNA expression in human epidermal
melanocytes. The gel shows b2-AR mRNA expression in melanocytes.
Lane 1, negative control (no cDNA); lane 2, melanocytes, lane 3, DNA
ladder. The weak expression in melanocytes can be attributed to the
interference of melanin (Eckhart et al, 2000).
Figure 5
Immunofluorescence of b2-adrenoceptor (b2-AR) expression on melanocytes in situ and in vitro. Rhodamine-conjugated anti b2-AR staining
(red) shows the expression of b2-AR (a). The presence of the receptors are mainly seen in the undifferentiated cells in the basal layer confirming
previous results (Schallreuter et al, 1995). Co-localization of the melanocyte-specific gp 100 protein (NKI/Beteb) and the b2-AR antibody identifies
the presence of b2-AR protein expression in epidermal melanocytes in situ (arrow, inset i in a) (scale bar¼ 50 mm). (b) b2-AR expression in human
epidermal cultured melanocytes. Note the presence of a strong dendritic expression of this receptor (scale bar¼10 mm).
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b2-adrenergic signal leading to both increased cAMP
production and melanogenesis. Interestingly, these cells
do not express b1-AR. Only recently, the importance of TH
isoform I was documented in the initiation of melanogenesis
in melanosomes (Marles et al, 2003). Since TH is also the
rate-limiting enzyme for catecholamine synthesis (Nagatsu
et al, 1964), we re-examined for the presence of other
enzymes in the catecholamine biosynthesis in melanocytes.
Surprisingly, PNMT protein could not be detected under the
experimental conditions used. By comparison with TH,
staining for DDC and DbH showed only a cytosolic pattern
with concentrations towards the periphery of the melano-
cyte. Clearly, the peri-nuclear site is not occupied. Hence,
the soluble cytosolic forms of these enzymes, including TH,
implicated autocrine catecholamine synthesis in these cells,
as already documented in chromaffin cells of the adrenal
medulla and in human epidermal undifferentiated keratino-
cytes (Pickel et al, 1975; Schallreuter et al, 1995).
Hence, the stimulation of melanogenesis by the b2-AR/
cAMP signal in melanocytes underlines the symbiotic
relationship in the epidermal unit and supports an important
role for both melanocytes and keratinocytes in the regulation
of pigmentation via cAMP. Nowadays, it is established that
cAMP plays a pivotal role in the regulation of skin pig-
mentation (Abe et al, 1969a, b; Pavel and Schwippelova,
1978; Thody et al, 1984; Abdel Malek et al, 1986a, b; Rees
and Flanagan, 1999). In this context, it has been reported
that binding of a-MSH to the G-protein-coupled melanocor-
tin type 1 receptor (MC1R) involves activation of AC followed
by elevation of intracellular cAMP levels, which in turn
activates PKA (Pavel and Schwippelova, 1978; Abdel Malek
et al, 1986a, b). The validity of these results is supported
in vivo by patients with MacCune–Albright syndrome dis-
playing large hypopigmented areas caused by a mutation in
the Gas protein in association with decreased cAMP levels
(Schwindinger et al, 1992). Further support stems from the
pigmenting effect of a-MSH mimicked in vitro by forskolin,
which directly binds and activates AC (Miyazaki et al, 1984).
Taken together, the above observations clearly demonstrate
an important role for the cAMP pathway in the regulation of
skin pigmentation. So far, this signal was only attributed to
the a-MSH/MC1 receptor cascade (Thody et al, 1984; Abdel
Malek et al, 1986a; Rees and Flanagan, 1999). Based on the
results presented herein, the cAMP signal transduction in
melanocytes cannot be exclusively invoked from this
a-MSH/MCl receptor signal. In this context, it is tempting
to revisit the presence of eumelanin biosynthesis in the hair
of the pro-opiomelanocortins (POMC) knockout mouse
because cAMP production may well have occurred via the
b2-AR signal in those murine melanocytes.
1
In summary, the discovery of the b2-AR signalling
cascade together with cAMP production/melanogenesis in
Figure 6
Saturation binding of b2-adrenoceptor (b2-AR) by ()[3H]CGP
12177 and cyclic adenosine monophospate (cAMP) production in
human melanocytes after stimulation with epinephrine (109–105
M). The inset shows the specific binding for b2-AR on melanocytes
under in vitro conditions (mean of duplicates). Based on these results,
the receptor numbers were calculated as outlined in methods, yielding
4230 receptors per cell with a KD of 3.19 nM. The function of the b2-AR
signal was followed by measuring the cAMP response after stimulation
with epinephrine (109–105 M) compared with unstimulated controls.
Experiments were performed in duplicates. cAMP is produced in a
concentration-dependent response. These results are in agreement
with a low-affinity b2-AR as observed in lymphocytes. The standard of
the mean (SEM) is shown as error bars. The response is significant in
the concentration range 108–105 M compared with unstimulated
controls (po0.01). Considering the physiological epidermal concentra-
tion of 106 M epinephrine, the result shows an 8-fold increase in cAMP
production after stimulation at this level.
Figure7
Increased cyclic adenosine monophospate (cAMP) and melanin
production in human melanocytes after stimulation with salbuta-
mol. The result shows cAMP production in human melanocytes after
simulation with a specific b2-adrenoceptor agonist salbutamol (10
8–
105 M) compared with unstimulated controls. The inset shows melanin
production after stimulation with the same ligand for 48 h. The melanin
formation follows cAMP response at the same concentrations. All
experiments were performed in duplicates. The results are in agree-
ment with low-affinity receptor response as observed after stimulation
with epinephrine.
1Barsh G: Agouti—past, present and future (abstract). 1st Interna-
tional Workshop on Cutaneous Neuroendocrinology, Hamburg,
Germany, 2002.
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melanocytes adds another source for this important second
messenger to the list and provides a new link in control
of pigmentation by the catecholamines. Considering that
melanocytes express low-affinity b2-AR the induction of
melanogenesis via this signal relies on the concentration of
available ligand. Since catecholamines are also known as
stress-related hormones, melanin production clearly mirrors
stress response.
It will be tempting to investigate whether melanocyte
adhesion and migration via extracellular signal-related
kinase 1 phosphorylation are influenced via b2-AR signalling
as observed in keratinocytes (Angers-Loustau et al, 1999;
Chen et al, 2002; Pullar et al, 2003). Clearly, more research is
needed to study the role of catecholamines and the b2-AR/
cAMP response in melanocytes.
Materials and Methods
Cell culture of epidermal melanocytes Human melanocytes cell
cultures were established from breast reduction and from face-lift
skin from healthy individuals (skin photo type III, Fitzpatrick
classification) (Fitzpatrick, 1988) in standard MCDB 153 medium
using the method of Pittelkow and Shipley (1989). Three weeks
prior to the experiments, the culture medium was changed to
keratinocyte serum-free medium (K-SFM), supplemented with
epidermal growth factor (EGF), bovine pituitary extract (BPE) and
2% fetal calf serum (FCS) (all from GibcoBRL, Paisley, UK). Cells
used in the experiment were harvested in the third to fourth
passages. The study was approved by the local ethics committee
and in agreement with the Helsinki Declaration Principles.
Immunohistochemical studies For in situ immunohistochemical
detection, we used full-thickness human skin biopsies obtained
under local anesthesia from healthy controls of skin photo type III
(Fitzpatrick classification) (Fitzpatrick, 1988). For in vitro studies,
melanocytes were grown on chamber slides (Nalge Nunc Interna-
tional, Naperville, Ilinois). Cells and sections were fixed in ice-cold
methanol (100%) for 4 min at room temperature (RT) immediately
prior to staining. Briefly sections/cells were incubated for 20 min in
a solution of hydrogen peroxide: methanol (1:4). Subsequently,
samples were incubated for 60 min at RTwith the primary antibody
containing 0.2% bovine serum albumin (BSA) and 0.3% Triton X-
100, followed by incubation for 20 min with secondary antibody
activated by peroxidase-labelled streptavidin (DAKO, Carpinteria,
California). 3-Amino-9-ethylcarbazole 3% (AEC) was used as a
chromogen and developed under microscopic control with a Leica
DM IRB inverted microscope (Leica, Wetzlar, Germany). Sections
were washed 3  with phosphate-buffered saline (PBS) between
steps. For embedding, glycergel mounting medium (Sigma-Aldrich,
Dorset, UK) was used. For the negative control, the primary
antibody was omitted and samples were incubated with 0.2% BSA
and 0.3% Triton X-100 only.
Single and double immunoﬂuorescence studies For detection
of enzyme/receptor protein in/on melanocytes, double staining
was performed. The monoclonal melanocyte-specific gp 100
protein (NKI/Beteb) was utilized together with specific antibodies
for the enzymes and receptors. Table I summarizes the details for
all antibodies used. Fluorescein isothiocyanate conjugated donkey
anti-mouse was used as a secondary antibody for gp 100 (NKI/
Beteb) and tetramethyl rhodoamine isothiocyanate (TRITC) con-
jugated donkey anti-rabbit/mouse was utilized as a secondary
layer to detect enzymes/receptors (Jackson Immuno Research,
Inc., Pennsylvania). Briefly, sections were blocked for 60 min with
10% normal donkey serum (NDS) in PBS (pH 7.4). Subsequently,
specimens were incubated with both primary antibodies. Each
step was followed by incubation for 1 h at RT, with the respective
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secondary antibody. All specimens were washed 3–5  with PBS
and Tween 20 between each step of the procedure and prior to
embedding in glycergel mounting medium. For negative controls,
the primary antibodies were omitted from the blocking solution.
Sections and cells were viewed and captured using a Leica DM-
IRB inverted microscope with an Osram 50 W Hg fluorescence
lamp (Optivision, Ossett, West Yorkshire, UK) coupled to a JVC
3CCD digital camera (Optivision) and Neotech ‘‘Image Grabber
PCI’’ imaging software.
RT-PCR Total mRNA was extracted from cells prior to the fourth
passage using the Ambion Totally RNA isolation kit (AMS
Biotechnology, Oxfordshire, UK) based on the guanidium iso-
thiocyanate method. cDNA was synthesized using the reverse
transcription system (Promega, Southampton, UK) and oligo
deoxythymidine triphosphate (DT) primers were incubated at
421C for 1 h, followed by a 5 min denaturation step at 951C.
PCR assays were conducted as described previously (Schallreuter
et al, 1998). All primers were obtained from Genosys Biotechnol-
ogies, Europe Ltd (Pampisford, UK). Primer sequences and
thermal parameters are described in Table II. Denaturation of
double-stranded DNA was achieved at 951C for 1 min followed by
annealing of primers to the target sequence, at a temperature
specific to each primers set, for 1 min (for details see Table II). New
strand synthesis by recombinant Taq DNA polymerase was
accomplished at 721C for 1 min. These three consecutive phases
were cycled 35 times. Finally, reactions were incubated at 721C
for 11 min. PCR products were analyzed by 1.5% agarose gel
electrophoresis with ethidium bromide staining.
b2-AR saturation binding Saturation binding was performed
using primary melanocyte cell cultures. A non-selective b2-AR anta-
gonist ()CGP 12177 [()(t-butylamino-2-hydroxy-propoxy)-
5,7-[3H] labelled benzimidazole-2-one] (Amersham Lifescience,
Amersham, UK) was used as the radioligand for all binding
experiments. All experiments were carried out in duplicate.
Specific binding of ()[3H]CGP 12177 to b2-AR was determined
by subtracting non-specific binding, in the presence of the non-
specific antagonist, propranolol (50 mM) (Sigma Chemical Com-
pany, St Louis, Missouri), from the total binding in experiments with
radioligand alone. Cells were incubated in a total volume of 2.0 mL
K-SFM culture medium for 60 min with the radioligand to ensure
saturation equilibrium. Reactions were terminated at 60 min by
removal of the culture medium followed by two washes with 1.0 mL
0.1 mM Tris buffer, pH 7.4. Cells were harvested by trypsination.
Protein concentrations were determined using the method by Kalb
and Bernlohr (1977). Aliquots of 0.5 mL were counted in 4.0 mL of
scintillation fluid (Beckman Coulter Inc, Fullerton, California) in a
Tri-Carb 2100 TR liquid scintillation analyzer on the [3H]-channel.
The counts were standardized to counts per minute (c.p.m.) per
milligram of melanocyte protein. The number of receptors present
on each cell were calculated using Avogadro’s number assuming
that 107 melanocytes represents 1 mg cellular protein (Schallreuter
et al, 1995).
cAMP assay To investigate the functionality of the b2-AR signal on
human melanocytes, cAMP levels were followed after stimulation
of the receptor. For this purpose, cells were seeded in six-well
plates at 1  105 cells per well and allowed to attach and grow for
3–8 d, depending on the cell type. Cells were then incubated at
371C in SFM containing 1 mM 3-isobutyl-methylxanthine (IBMX)
(Sigma-Aldrich) for 20 min. Subsequently, epinephrine or salbuta-
mol (Sigma-Aldrich) was added at concentrations 109–105 M
and 108–105 M, respectively, and was followed by incubation for
60 min at 371C. Briefly, cells were put on ice and for cell lysis
700 mL of ice-cold 99% ethanol was added. Cells were harvested
and centrifuged at 4,000 g for 3 min. The supernatants were vacuum
dried in a Univapo 100 H (UniEquip, Martinsried, Germany) and
cAMP was determined using a commercially available kit (Amer-
sham, UK; TRK 243) following the manufacturers protocol. Briefly,
50 mL of Tris buffer (pH 7.4) was added to each sample, followed
by vortexing. Fifty microliters of [3H]cAMP together with 100 mL of
binding protein were then added to each sample, followed by
further vortexing. Subsequently, the samples were kept at 41C in
the fridge for 1.5 h to allow the radioactive labelled cAMP to bind.
Hundred microliters of the charcoal adsorbent was then added to
each sample, followed by centrifugation for 5 min at 4,000 g An
Table II. PCR primers: methods and sources
Oligonucleotide sequence 50–30 Tm (1C)
Primer
applied (lM)
Annealing
(1C)
MgCl2
(mM) DMSO
Genbank accession number
of target gene sequence
Amplicon
size (bp)
hTH-isoform specific 0.7 63.2 3.0 Yes M17589 with appropriate
deletions (Kaneda et al, 1987)
327
GGCCATCATGTCCCCGCGGT 77.3
ACCTCGAGGCGCACGAAGTA 69.2
DDC 1.0 64.5 1.0 — M88700 146
GGGGACCACAACATGCTGCTC 71.2
CCACTCCATTCAGAAGGTGCC 67.9
PNMT 1.0 55.8 1.5 — XM008597 718
GCCTACCTCCGCAACAACTA 64.0
AGACGCCCTTGACATCATCT 63.6
b2-adrenoceptor 1.0 57.5 2.0 — JO2960 599
CTGGTCATGGGCCTAGCAGT 63.9
CATGATGATGCCTAACGTCT 63.9
b1-adrenoceptor 1.0 55 2.0 — AF169007 Not found
CCCAGAAGCAGGTGAAGAAG 63.8
TAGATGATGGGGTTGAAGGC 63.7
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aliquot of 200 mL of the supernatant was counted in 4 mL Ready-
Safe liquid scintillation cocktail (Beckman Coulter) using the [3H]
channel of a Tri-Carb 2100 TR liquid scintillation analyzer.
Determination of cellular melanin content Cells were seeded in
six-well plates at a density of 1  105 cells per well. Salbutamol
was added to the melanocytes and left for 48 h. At the end of the
incubation period, cells were washed with PBS and centrifuged
and the pellets were collected. These pellets were dissolved in 400
mL of 1 M NaOH and melanin was measured in a Beckman DU 64
spectrophotometer at 475 nm against a 1 M NaOH blank. The
melanin content was determined in micrograms from a synthetic
melanin standard curve and correlated to milligram protein using
the method of Kalb and Bernlohr (1977).
Statistical analysis The cAMP and melanin production were
analyzed using the Student’s t test.
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